These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 28593885)
21. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
23. Association between molecular subtypes and lymph node status in invasive breast cancer. Si C; Jin Y; Wang H; Zou Q Int J Clin Exp Pathol; 2014; 7(10):6800-6. PubMed ID: 25400761 [TBL] [Abstract][Full Text] [Related]
24. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer? Falck AK; Fernö M; Bendahl PO; Rydén L World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203 [TBL] [Abstract][Full Text] [Related]
25. Higher Ki67 expression is associates with unfavorable prognostic factors and shorter survival in breast cancer. Kilickap S; Kaya Y; Yucel B; Tuncer E; Babacan NA; Elagoz S Asian Pac J Cancer Prev; 2014; 15(3):1381-5. PubMed ID: 24606469 [TBL] [Abstract][Full Text] [Related]
26. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer. Paksoy SE; Tasdelen I; Balaban AS; Ozkaya G; Tolunay S Bratisl Lek Listy; 2013; 114(11):645-9. PubMed ID: 24236435 [TBL] [Abstract][Full Text] [Related]
27. Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. Orucevic A; Reddy VB; Bloom KJ; Bitterman P; Magi-Galluzzi C; Oleske DM; Phillips M; Gould VE; Cobleigh M; Wick MR; Gattuso P Breast J; 2002; 8(6):349-55. PubMed ID: 12390357 [TBL] [Abstract][Full Text] [Related]
28. Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer. Schneider J; Pollán M; Ruibal A; Jiménez E; Lucas AR; Núñez MI; Sánchez J; Tejerina A Tumour Biol; 1999; 20(6):319-30. PubMed ID: 10567878 [TBL] [Abstract][Full Text] [Related]
29. [Molecular features of breast cancer predictive of lymph node metastases]. Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H Rev Assoc Med Bras (1992); 2008; 54(3):203-7. PubMed ID: 18604396 [TBL] [Abstract][Full Text] [Related]
30. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival. Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770 [TBL] [Abstract][Full Text] [Related]
31. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
32. p53 expression in breast cancer predicts tumors with low probability of non-sentinel nodes infiltration. Vernet-Tomás M; Baños N; Sabadell D; Corominas JM; Mestre-Fusco A; Suárez-Piñera M; Carreras R J Obstet Gynaecol Res; 2015 Jul; 41(7):1115-21. PubMed ID: 25657069 [TBL] [Abstract][Full Text] [Related]
33. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis. Ba JL; Liu CG; Jin F Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206 [TBL] [Abstract][Full Text] [Related]
34. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up. Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420 [TBL] [Abstract][Full Text] [Related]
35. Primary tumour characteristics and axillary lymph node status in breast cancer. Yiangou C; Shousha S; Sinnett HD Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048 [TBL] [Abstract][Full Text] [Related]
36. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study. Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895 [TBL] [Abstract][Full Text] [Related]
37. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients. Gago FE; Tello OM; Diblasi AM; Ciocca DR J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692 [TBL] [Abstract][Full Text] [Related]
38. Role of axillary node dissection in patients with T1a and T1b breast cancer: Mayo Clinic experience. Mincey BA; Bammer T; Atkinson EJ; Perez EA Arch Surg; 2001 Jul; 136(7):779-82. PubMed ID: 11448390 [TBL] [Abstract][Full Text] [Related]
39. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177 [TBL] [Abstract][Full Text] [Related]
40. Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes. Dikicioglu E; Barutca S; Meydan N; Meteoglu I Int J Clin Pract; 2005 Sep; 59(9):1039-44. PubMed ID: 16115179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]